Editorial Board for section 'Therapeutic Vaccines and Antibody Therapeutics'

Please see the section webpage for more information on this section.

Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.

Members

*
Website
Section Editor-in-Chief
1. Department of Rheumatology, Immunology and Allergology, Inselspital, Bern University Hospital, University of Bern, 3012 Bern, Switzerland
2. Department for BioMedical Research, University of Bern, 3012 Bern, Switzerland
3. Nuffield Department of Medicine, The Jenner Institute, The Henry Wellcome Building for Molecular Physiology, University of Oxford, Oxford OX1 2JD, UK
Interests: therapeutic vaccines; non-communicable diseases; cancer; virus-like particles; antibody therapies; immunology; memory
* Section: Therapeutic Vaccines and Antibody Therapeutics
Special Issues, Collections and Topics in MDPI journals

Website
Section Board Member
Department of Medicine, Mayo Clinic, Rochester, MN 55902, USA
Interests: gene-based vaccines; gene therapy; oncolytic virotherapy
Special Issues, Collections and Topics in MDPI journals

Website
Section Board Member
1. Centre for Biomedical Research, Burnet Institute, Melbourne, VIC 3004, Australia
2. Department of Medicine, University of Melbourne, Melbourne, VIC 3050, Australia
3. Department of Microbiology, Monash University, Melbourne, VIC 3800, Australia
Interests: malaria vaccines; antibodies; childhood vaccines; neutrophils; monocytes; complement; implementation

Website
Section Board Member
Department of Molecular Microbiology and Immunology, St. Louis University, 1100 S Grand Blvd, MO 63103, USA
Interests: antigen specific B cell responses; antibody responses
Special Issues, Collections and Topics in MDPI journals

Website
Section Board Member
Department of Molecular and Cellular Biology, College of Osteopathic Medicine, Sam Houston State University, Conroe, TX 77304, USA
Interests: development of antiviral small molecules and antibodies
Special Issues, Collections and Topics in MDPI journals

Website
Section Board Member
Department of Veterinary Medicine, College of Veterinary Medicine, Gyeongsang National University, Jinju City, Gyeongnam 52828, Republic of Korea
Interests: fish vaccine; fish lymphocyte; aquaculture; variable lymphocyte receptors of hagfish

Website
Section Board Member
School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia
Interests: development of vaccines; therapeutic monoclonal antibodies (mAbs); stabilization and formulation of vaccines and mAbs; nanoparticles; protein folding and aggregation
Special Issues, Collections and Topics in MDPI journals

Website
Section Board Member
1. Molecular and Cellular Immunology/Immune Regulation, Center for Regenerative Therapies Dresden (CRTD), 01307 Dresden, Germany
2. Center for Molecular and Cellular Bioengineering (CMCB), Technische Universität Dresden (TUD), 01069 Dresden, Germany
Interests: molecular and cellular immunology/immune regulation


Section Board Member
1. Division of Clinical Neuroscience, Section of Clinical Neurology, University of Nottingham, Nottingham NG7 2UH, UK
2. Department of Neurology, Nottingham University Hospitals NHS Trust, Nottingham NG7 2UH, UK
Interests: human herpesviruses; neurodegenerative diseases; COVID-19
Special Issues, Collections and Topics in MDPI journals

Website
Section Board Member
Department of Health Development and Medicine, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan
Interests: DNA vaccine for hypertension; diabetes and dyslipidemia; translational research of novel antimicrobial peptides; vascular biology (anti-angiogenesis and vascular calcification)

Website
Section Board Member
Division of Oncology/Hematology, Department of Internal Medicine, Korea University, Seoul 02841, Republic of Korea
Interests: breast cancer; prostate cancer; ctDNA; exosome; NGS
Special Issues, Collections and Topics in MDPI journals

Website
Section Board Member
1. GIMAP EA 3064, Medicine Faculty of Saint-Etienne, University of Lyon, 69007 Lyon, France
2. Laboratory of Immunology, University Hospital Saint-Etienne, 42055 Saint-Etienne, France
Interests: mucosal vaccination; adjuvant; IgA; antibody; microbiota

Website
Section Board Member
Department of Chemistry and Biochemistry, Montana State University, Bozeman, MT 59717, USA
Interests: antibody function; antibody therapies; cytotoxic immunoconjugates; immunotoxins; HIV; SARS-CoV

Website
Section Board Member
Medical Research Center (MRC) for Immunotherapy of Cancer, Chonnam National University Medical School, Hwasun 58128, Korea
Interests: mucosal vaccine; adjuvant; TLR biology; tumor immunotherapy; cancer vaccine

Website
Section Board Member
Department of Health Development and Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan
Interests: stroke; vaccines; inflammation; neurology

Website
Section Board Member
Global Immunization Division, U.S. Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Interests: hepatitis B; tetanus; maternal and neonatal tetanus; vaccine preventable diseases; epidemiology; immunization; public health; global health; serological surveys of vaccine preventable diseases

Website
Section Board Member
Institut de Biologie Structurale (IBS), University Grenoble Alpes, CEA, CNRS, 38000 Grenoble, France
Interests: HIV-1; Env; gp41; MPER; neutralizing antibodies; vaccine design; ESCRT; membrane fission; budding; X-ray crystallography

Website
Section Board Member
BIO-IT Foundry Technology Institute, Pusan National University, Busan, Republic of Korea
Interests: cancer immunotherapy; virotherapy; regenerative therapy
Special Issues, Collections and Topics in MDPI journals

grade Website
Section Board Member
Shenzhen Third People’s Hospital, Second Hospital Affiliated to Southern University of Science and Technology, No. 29, Bulan Road, Longgang District, Shenzhen 518112, China
Interests: cross-neutralization of SARS-CoV-2 kappa and delta variants by inactivated vaccine-elicited serum and monoclonal antibodies
Special Issues, Collections and Topics in MDPI journals
Back to TopTop